Lapatinib could extend survival in women with Her2-positive breast cancer

[News]

Treatment with lapatinib could extend survival in women with Her2-positive breast cancer that has spread to the brain, according to research published in the British Journal of Cancer.

More... (http://www.news-medical.net/news/20111130/Lapatinib-could-extend-survival-in-women-with-Her2-positive-breast-cancer.aspx)